Clinical Trials

Gastrointestinal Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 2 of 2 Clinical Trials Related to Gastrointestinal Cancer

MSK 19-377 Gastric Cancer

A Phase 2, Open-Label, Single-Arm Trial of Trastuzumab Deruxtecan (DS-8201A) in HER2-Positive, Unresectable or Metastatic Gastric or Gastro-Esophageal Junction (GEJ) Adenocarcinoma Subjects Who Have Progressed on or After a Trastuzumab

Doctor(s) Running This Study

S1922

Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma

Doctor(s) Running This Study